HEADER HYDROLASE/HYDROLASE INHIBITOR 24-APR-02 1LK6 TITLE STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE TITLE 2 LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: L, I; COMPND 4 SYNONYM: SERINE (OR CYSTEINE) PROTEINASE INHIBITOR, CLADE C; COMPND 5 ANTITHROMBIN, MEMBER 1; ANTITHROMBIN III; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ANTITHROMBIN P14-P9 PEPTIDE; COMPND 8 CHAIN: C; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 3; COMPND 11 MOLECULE: EXOGENOUS TRIPEPTIDE FORMYL-MLF; COMPND 12 CHAIN: D; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: THIS SEQUENCE OCURS NATURALLY IN HUMAN ANTITHROMBIN; SOURCE 9 MOL_ID: 3; SOURCE 10 SYNTHETIC: YES KEYWDS LOOP-SHEET POLYMER, BETA-BARREL, BLOOD CLOTTING, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.ZHOU,J.A.HUNTINGTON,D.A.LOMAS,R.W.CARRELL,P.E.STEIN REVDAT 6 16-OCT-24 1LK6 1 REMARK REVDAT 5 16-AUG-23 1LK6 1 HETSYN REVDAT 4 29-JUL-20 1LK6 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1LK6 1 VERSN REVDAT 2 24-FEB-09 1LK6 1 VERSN REVDAT 1 03-JUN-03 1LK6 0 JRNL AUTH A.ZHOU,P.E.STEIN,J.A.HUNTINGTON,R.W.CARRELL JRNL TITL SERPIN POLYMERIZATION IS PREVENTED BY A HYDROGEN BOND JRNL TITL 2 NETWORK THAT IS CENTERED ON HIS-334 AND STABILIZED BY JRNL TITL 3 GLYCEROL JRNL REF J.BIOL.CHEM. V. 278 15116 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12578831 JRNL DOI 10.1074/JBC.M211663200 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 27351 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1374 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE : 0.3460 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6603 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 126 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.54000 REMARK 3 B22 (A**2) : 9.09000 REMARK 3 B33 (A**2) : -8.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.53000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.64 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD TARGET REMARK 4 REMARK 4 1LK6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016019. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : COOLED LIQUID GALLIUM REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27376 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 37.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : 0.08700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.55100 REMARK 200 R SYM FOR SHELL (I) : 0.43100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P8 REMARK 200 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE (1JVQ). BOTH REMARK 200 PEPTIDES OMITTED IN STARTING MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM CACODYLATE, AMMONIUM REMARK 280 FLUORIDE, GLYCEROL, PH 6.8, VAPOR DIFFUSION, HANGING DROP AT 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 49.95400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, I, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 ARG L 24 REMARK 465 SER L 25 REMARK 465 PRO L 26 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 39 REMARK 465 ILE L 40 REMARK 465 PRO L 41 REMARK 465 GLU L 42 REMARK 465 ALA L 43 REMARK 465 THR L 44 REMARK 465 LYS L 432 REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 LYS I 28 REMARK 465 LYS I 29 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 39 REMARK 465 ILE I 40 REMARK 465 PRO I 41 REMARK 465 GLU I 381 REMARK 465 ALA I 382 REMARK 465 ALA I 383 REMARK 465 LYS I 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO L 12 47.61 -68.32 REMARK 500 ARG L 13 -35.00 -151.32 REMARK 500 PRO L 16 53.71 -67.50 REMARK 500 PRO L 19 130.17 -36.00 REMARK 500 ASN L 96 -127.68 61.74 REMARK 500 LYS L 107 19.92 48.73 REMARK 500 ASP L 109 0.51 -61.36 REMARK 500 SER L 112 85.48 -57.18 REMARK 500 LYS L 114 -26.21 -143.89 REMARK 500 THR L 199 -79.16 -97.87 REMARK 500 SER L 204 -83.70 -47.99 REMARK 500 GLU L 205 22.24 -75.77 REMARK 500 GLU L 209 -33.98 -37.78 REMARK 500 LYS L 222 117.64 -169.71 REMARK 500 ALA L 242 -86.07 -30.44 REMARK 500 ARG L 261 123.26 170.42 REMARK 500 VAL L 263 -161.91 -109.97 REMARK 500 GLU L 289 -20.23 81.15 REMARK 500 GLU L 310 5.42 -59.64 REMARK 500 ASP L 342 -70.57 -44.21 REMARK 500 LEU L 343 -34.00 -31.16 REMARK 500 ASP L 361 50.32 72.92 REMARK 500 PRO L 397 118.89 -36.26 REMARK 500 ARG L 399 147.38 176.36 REMARK 500 PHE L 402 67.18 174.60 REMARK 500 ALA L 404 -125.37 -127.60 REMARK 500 ARG L 406 58.63 39.33 REMARK 500 ASN I 18 55.16 29.27 REMARK 500 PRO I 26 -148.45 -60.94 REMARK 500 ALA I 43 21.89 165.58 REMARK 500 THR I 44 -161.30 -103.90 REMARK 500 ASN I 96 -132.63 56.35 REMARK 500 LYS I 107 15.92 48.32 REMARK 500 ILE I 111 78.28 -117.51 REMARK 500 SER I 112 122.85 -17.77 REMARK 500 GLU I 113 19.23 53.93 REMARK 500 SER I 116 -34.06 -34.45 REMARK 500 TYR I 131 52.75 -99.63 REMARK 500 ALA I 134 -170.22 -63.06 REMARK 500 GLU I 177 -61.62 -99.59 REMARK 500 ASN I 178 56.94 -101.49 REMARK 500 THR I 199 -102.23 -95.54 REMARK 500 ASP I 200 63.06 -69.39 REMARK 500 ILE I 207 115.74 60.90 REMARK 500 LYS I 228 144.97 -37.32 REMARK 500 LYS I 241 177.25 -57.89 REMARK 500 ARG I 261 132.53 -171.41 REMARK 500 VAL I 263 -165.53 -102.50 REMARK 500 ALA I 264 142.90 -37.94 REMARK 500 GLU I 265 49.02 38.75 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BR8 RELATED DB: PDB REMARK 900 2.9A STRUCTURE OF BINARY COMPLEXED ANTITHROMBIN. THIS IS DIMERIC REMARK 900 ANTITHROMBIN COMPLEXED WITH A 12 RESIDUE PEPTIDE CORRESPONDING TO REMARK 900 P14-P3 OF THE REACTIVE CENTRE LOOP REMARK 900 RELATED ID: 1JVQ RELATED DB: PDB REMARK 900 STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P8 REACTIVE REMARK 900 LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE DBREF 1LK6 L 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1LK6 I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1LK6 C 2 7 PDB 1LK6 1LK6 2 7 DBREF 1LK6 D 10 12 PDB 1LK6 1LK6 10 12 SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 C 7 ACE SER GLU ALA ALA ALA SER SEQRES 1 D 3 FME LEU PHE MODRES 1LK6 FME D 10 MET N-FORMYLMETHIONINE HET ACE C 1 3 HET FME D 10 10 HET NDG L 801 15 HET NDG L 841 15 HET NDG L 842 15 HET NDG I 801 15 HET NAG I 841 15 HET NDG I 842 15 HET NAG I 861 15 HET NDG I 862 15 HET GOL C 100 6 HETNAM ACE ACETYL GROUP HETNAM FME N-FORMYLMETHIONINE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ACE C2 H4 O FORMUL 4 FME C6 H11 N O3 S FORMUL 5 NDG 6(C8 H15 N O6) FORMUL 9 NAG 2(C8 H15 N O6) FORMUL 13 GOL C3 H8 O3 FORMUL 14 HOH *34(H2 O) HELIX 1 1 ASN L 45 SER L 69 1 25 HELIX 2 2 SER L 79 LEU L 92 1 14 HELIX 3 3 CYS L 95 PHE L 106 1 12 HELIX 4 4 LYS L 107 ILE L 111 5 5 HELIX 5 5 ASP L 117 ARG L 132 1 16 HELIX 6 6 ASN L 155 TYR L 166 1 12 HELIX 7 7 ASP L 174 THR L 194 1 21 HELIX 8 8 PRO L 203 ILE L 207 5 5 HELIX 9 9 SER L 230 THR L 234 5 5 HELIX 10 10 ALA L 264 GLY L 266 5 3 HELIX 11 11 LEU L 292 LYS L 297 1 6 HELIX 12 12 THR L 300 GLU L 310 1 11 HELIX 13 13 LEU L 331 MET L 338 1 8 HELIX 14 14 VAL L 341 SER L 345 5 5 HELIX 15 15 ASP I 6 ALA I 10 5 5 HELIX 16 16 LYS I 11 ILE I 15 5 5 HELIX 17 17 ASN I 45 SER I 69 1 25 HELIX 18 18 SER I 79 LEU I 92 1 14 HELIX 19 19 CYS I 95 PHE I 106 1 12 HELIX 20 20 LYS I 107 ILE I 111 5 5 HELIX 21 21 ASP I 117 TYR I 131 1 15 HELIX 22 22 ASN I 155 GLY I 167 1 13 HELIX 23 23 ASP I 174 THR I 194 1 21 HELIX 24 24 SER I 230 THR I 234 5 5 HELIX 25 25 ALA I 264 GLY I 266 5 3 HELIX 26 26 SER I 291 LEU I 299 1 9 HELIX 27 27 THR I 300 LEU I 311 1 12 HELIX 28 28 LEU I 331 MET I 338 1 8 HELIX 29 29 VAL I 341 SER I 345 5 5 HELIX 30 30 PRO I 416 ASN I 418 5 3 SHEET 1 415 LYS L 139 ASP L 149 0 SHEET 2 415 LEU L 213 LEU L 224 -1 N VAL L 214 O PHE L 147 SHEET 3 415 GLY L 379 ILE L 390 -1 N SER L 380 O GLY L 223 SHEET 4 415 VAL L 364 VAL L 375 -1 N SER L 365 O VAL L 389 SHEET 5 415 GLU L 312 SER L 330 -1 O PHE L 323 N VAL L 375 SHEET 6 415 THR I 386 ILE I 390 1 O ALA I 387 N VAL L 317 SHEET 7 415 GLU L 312 SER L 330 1 O MET L 315 N ALA I 387 SHEET 8 415 SER L 250 ARG L 262 -1 O SER L 250 N ARG L 322 SHEET 9 415 ARG L 235 LYS L 236 -1 O ARG L 235 N MET L 251 SHEET 10 415 SER L 250 ARG L 262 -1 N MET L 251 O ARG L 235 SHEET 11 415 GLN L 268 PRO L 273 -1 N VAL L 269 O ARG L 261 SHEET 12 415 ILE L 279 LEU L 285 -1 O MET L 281 N LEU L 272 SHEET 13 415 PHE L 408 GLU L 414 -1 N LEU L 409 O ILE L 284 SHEET 14 415 THR L 419 VAL L 426 -1 O THR L 419 N GLU L 414 SHEET 15 415 ILE L 76 LEU L 78 -1 O ILE L 76 N ARG L 425 SHEET 1 3 1 VAL L 355 GLU L 357 0 SHEET 1 18 9 THR I 419 VAL I 426 0 SHEET 2 18 9 PHE I 408 GLU I 414 -1 O PHE I 408 N VAL I 426 SHEET 3 18 9 ILE I 279 LEU I 285 -1 N THR I 280 O ARG I 413 SHEET 4 18 9 GLN I 268 PRO I 273 -1 N GLN I 268 O LEU I 285 SHEET 5 18 9 SER I 246 ARG I 262 -1 O ARG I 259 N GLU I 271 SHEET 6 18 9 ARG I 235 TYR I 240 -1 O ARG I 235 N MET I 251 SHEET 7 18 9 SER I 246 ARG I 262 -1 O CYS I 247 N PHE I 239 SHEET 8 18 9 GLU I 312 PRO I 321 -1 O GLU I 312 N TYR I 260 SHEET 9 18 9 VAL I 400 LYS I 403 1 O VAL I 400 N VAL I 317 SHEET 1 20 5 LYS I 139 ASP I 149 0 SHEET 2 20 5 LEU I 213 LYS I 222 -1 O VAL I 214 N PHE I 147 SHEET 3 20 5 ALA C 4 SER C 7 -1 O ALA C 4 N PHE I 221 SHEET 4 20 5 PHE I 368 VAL I 375 -1 N LYS I 370 O SER C 7 SHEET 5 20 5 PHE I 323 SER I 330 -1 O PHE I 323 N VAL I 375 SSBOND 1 CYS L 8 CYS L 128 1555 1555 2.04 SSBOND 2 CYS L 21 CYS L 95 1555 1555 2.03 SSBOND 3 CYS L 247 CYS L 430 1555 1555 2.03 SSBOND 4 CYS I 8 CYS I 128 1555 1555 2.04 SSBOND 5 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 6 CYS I 247 CYS I 430 1555 1555 2.03 LINK C ACE C 1 N SER C 2 1555 1555 1.33 LINK C FME D 10 N LEU D 11 1555 1555 1.33 CRYST1 68.811 99.908 87.292 90.00 104.44 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014533 0.000000 0.003742 0.00000 SCALE2 0.000000 0.010009 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011830 0.00000